Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80d4d2a01c792109437552c3dd2af301 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64e5cadfa8a7d596f9106715f7655286 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c06d114257182ee7efd4c696c5fdb836 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6874 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2013-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10120c0ab264d012fa252b23d1d1a137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8b3ace378a766f6c6dbeae36d24ac3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18e5dc55a14a04ac576b12a4841e211f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8862db2bbd07cfa5664af025a5577b38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df113cc9e47e6cc31e257206f9bcbb52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96514a22f99eb2f3fe3defbc40b693a4 |
publicationDate |
2014-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2013226400-A1 |
titleOfInvention |
Methods for predicting anti-cancer response |
abstract |
The present invention relates to methods for predicting response of a cancer in a subject to anti-cancer therapies based upon a determination and analysis of a chromosomal aberration score, such as the number of allelic imbalance or the number of telomeric allelic imbalance in the chromosomes of the human genome. |
priorityDate |
2012-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |